# P20 Extending Sleep to Reverse Metabolic Syndrome

> **NCT03596983** · NA · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 44 (actual)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **BEHAVIORAL:** Sleep Intervention
- **BEHAVIORAL:** Week 2 Intervention

## Key facts

- **NCT ID:** NCT03596983
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-10
- **Primary completion:** 2021-06-04
- **Final completion:** 2021-06-04
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2024-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03596983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03596983, "P20 Extending Sleep to Reverse Metabolic Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03596983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*